SCHEMBL3922182

SCHEMBL3922182

O=C1CC=Cc2ccc3c(c21)-c1ccccc1C3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.43
CES1 P23141 2/20 0.41
BCHE P06276 1/20 0.41
ALDH1A1 P00352 6/20 0.36
MAP3K9 P80192 1/20 0.35
MAP3K11 Q16584 1/20 0.35
HTR2B P41595 2/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP2 O95551 1/20 0.34
CASP3 P42574 1/20 0.34
CASP7 P55210 1/20 0.34
CASP9 P55211 1/20 0.34
CASP6 P55212 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30403300 0.75 MAOA (0.56) MAOACES1BCHEALDH1A1MAP3K9
SCHEMBL7753388 0.74 MAPT (0.42) MAOAALDH1A1POLBKDM4EHPGD
SCHEMBL1053387 0.70 CES1 (0.46) MAOACES1BCHEALDH1A1MAP3K9
SCHEMBL18156790 0.68 MAOA (0.55) MAOACES1BCHEALDH1A1MAP3K9
SCHEMBL249997 0.68 CES1 (0.45) MAOACES1BCHEALDH1A1HTR2B
SCHEMBL29385734 0.68 CES1 (0.45) MAOACES1BCHEALDH1A1HTR2B
SCHEMBL31032356 0.67 SMN1; SMN2 (0.46) MAOAALDH1A1HTR2BKDM4EHPGD
SCHEMBL15119561 0.67 MAOA (0.48) MAOACES1BCHEALDH1A1MAP3K9
SCHEMBL8791995 0.67 CES1 (0.54) CES1ALDH1A1KDM4EHPGDMAPT
SCHEMBL1053278 0.67 CES1 (0.46) MAOACES1BCHEALDH1A1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2021841-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TRANSITIONS OPTICAL, INC. (US) 2009-02-11 EP disclosed
US-7481955-B2 Photochromic materials comprising metallocenyl groups TRANSITIONS OPTICAL, INC. (US) 2009-01-27 US disclosed
WO-2007140071-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TRANSITIONS OPTICAL, INC. (US) 2007-12-06 WO disclosed
US-20070278460-A1 Photochromic materials comprising metallocenyl groups TRANSITIONS OPTICAL LIMITED (IE) 2007-12-06 US disclosed
US-20070278461-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TRANSITIONS OPTICAL, INC. (US) 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070278461-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TELO2, EYA3, CRY2 MAOA 4651/4885CES1 2165/4885BCHE 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.